SCHEMBL785599

SCHEMBL785599

O=C(O)c1cc(F)c2c(c1)[C@H](NC(=O)c1ccccc1Cl)CC2

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
TAS1R3 Q7RTX0 10/20 0.47
TAS1R1 Q7RTX1 10/20 0.47
TAS1R2 Q8TE23 9/20 0.47
PYGL P06737 1/20 0.41
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
CCNA1 P78396 1/20 0.40
SPTLC2 O15270 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CRBN Q96SW2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784762 1.00 ALDH1A1 (0.52) ALDH1A1TAS1R3TAS1R1TAS1R2PYGL
SCHEMBL803561 0.88 ALDH1A1 (0.49) ALDH1A1TAS1R3TAS1R1TAS1R2SPTLC2
SCHEMBL883818 0.87 ALDH1A1 (0.52) ALDH1A1TAS1R3TAS1R1TAS1R2PYGL
SCHEMBL785920 0.82 ALDH1A1 (0.47) ALDH1A1TAS1R3TAS1R1TAS1R2PYGL
SCHEMBL786085 0.82 ALDH1A1 (0.47) ALDH1A1TAS1R3TAS1R1TAS1R2PYGL
SCHEMBL785249 0.81 ALDH1A1 (0.61) ALDH1A1TAS1R3TAS1R1TAS1R2PYGL
SCHEMBL484760 0.81 ALDH1A1 (0.61) ALDH1A1TAS1R3TAS1R1TAS1R2PYGL
SCHEMBL485126 0.81 ALDH1A1 (0.61) ALDH1A1TAS1R3TAS1R1TAS1R2PYGL
SCHEMBL785162 0.80 ALDH1A1 (0.57) ALDH1A1TAS1R3TAS1R1TAS1R2CYP1A2
SCHEMBL785361 0.80 ALDH1A1 (0.57) ALDH1A1TAS1R3TAS1R1TAS1R2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 ALDH1A1 1267/4885TAS1R3 202/4885TAS1R1 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.